Evidence map›Paper›PMID 37477337›Full record

ArticleActa obstetricia et gynecologica Scandinavica2023

A decade of change - lessons learned from prenatal diagnostics in Central Denmark region in 2008-2018.

Dorte Launholt Lildballe, Naja Becher, Else Marie Vestergaard, Rikke Christensen, Stina Lou, Puk Sandager, Lars Henning Pedersen, Kasper Gadsbøll, Olav Bjørn Petersen, Ida Vogel

Abstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort study.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2025
    Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dorte Launholt LildballeDepartment of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0003-0223-1673
Naja BecherCenter for Fetal Diagnostics, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID 0000-0003-1264-1940
Else Marie VestergaardDepartment of Clinical Biochemistry, Regional Hospital Horsens, Horsens, Denmark.ORCID 0000-0002-0469-3890
Rikke ChristensenDepartment of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-4069-7370
Stina LouCenter for Fetal Diagnostics, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID 0000-0001-6177-5780
Puk SandagerCenter for Fetal Diagnostics, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID 0000-0001-7153-7081
Lars Henning PedersenDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID 0000-0001-6726-1991
Kasper GadsbøllCenter for Fetal Medicine, Pregnancy and Ultrasound, Department of Obstetrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-1331-3503
Olav Bjørn PetersenCenter for Fetal Medicine, Pregnancy and Ultrasound, Department of Obstetrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-8517-4082
Ida VogelDepartment of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-1125-0393

Funding

Novo Nordisk Foundation NNF16OC0018772Novo Nordisk Foundation NNF18OC0054457Novo Nordisk Foundation NNFSA170030576
6 · The paper itself

Abstract

introductionIn 2011, it was decided to implement chromosomal microarray in prenatal testing in the Central Denmark Region, mainly due to the expected higher diagnostic yield. Chromosomal microarray was introduced gradually for an increasing number of pregnancies and without a transition period where both karyotyping and chromosomal microarray were performed: first malformations (2011), then large nuchal translucency (2013), then high risk at combined first trimester risk screening (2016) and finally for all indications (2018). This retrospective study summarizes 11 years of using chromosomal microarray in invasive prenatal testing and presents the effect on diagnostic yield and turnaround time. Furthermore, the concerns when introducing chromosomal microarray are presented and discussed. MATERIAL AND

methodsRegistry data from the Danish Fetal Medicine Database, the regional fetal medicine database, the Danish Cytogenetic Central Register and the local laboratory database at Department of Clinical Genetics were all combined, and a cohort of 147 158 singleton pregnancies with at least one ultrasound examination was established

resultsOf the 147 158 pregnancies, invasive sampling was performed (chorionic villi or amniocytes) in 8456, corresponding to an overall invasive rate of 5.8%. Between 2016 and 2018, 3.4% (95% confidence interval [CI] 2.8-4.2%; n = 86) of the invasive samples (n = 2533) had a disease causing copy number variant and 5.3% (95% CI 4.4-6.2%; n = 133) had trisomies and other aneuploidies. The turnaround time more than halved from 14 days to an average of 5.5 days for chorionic villus sampling.

conclusionsChromosomal microarray identified 5.3% trisomies and 3.4% copy number variants, thereby increased the diagnostic yield by more than 64% compared with karyotype only and it also more than halved the turnaround time. Some preliminary concerns proved real, eg prenatal counseling complexity, but these have been resolved over time in a clinical path with expert consultations.

Indexed as

Prenatal DiagnosisTrisomyChorionic Villi SamplingChromosome AberrationsDenmarkFemaleHumansPregnancyRetrospective Studieschromosomal aberrationschromosomal microarrayclinical laboratory techniquescopy number variationinterdisciplinary communicationprenatal diagnosisprenatal screening

Identifiers

PMID37477337
PMCPMC10577626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.